Business · 15/08/2019Updated: 10/17/2026 · 1 min read
FDA Releases Final Guidance for Osteoporosis Treatment Drugs
Summary
The FDA has announced the availability of a final guidance for industry, outlining recommendations for designing nonclinical bone quality studies to support the approval of osteoporosis treatment drugs and biologics.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →